Want to see JP:6645 full AI Analyst Report?
Top Page
OMRON
(6645)
Select Model
Select Model
Rating:67Neutral
Price Target:
¥7,196.00
▲(31.34% Upside)
Action:Reiterated
Date:08/09/26
The score is driven primarily by improving financial performance supported by a strong balance sheet and a clear bullish technical trend (price above key moving averages with positive MACD). Offsetting these positives, profitability and returns remain well below prior-cycle levels and the stock’s valuation is expensive (P/E ~37.5) with only a modest dividend yield, which caps the overall rating.
Positive Factors
Conservative balance sheet
Moderate leverage and a stable equity base provide financial flexibility and resilience during industrial downturns, allowing OMRON to continue investing in automation and healthcare capabilities.
Negative Factors
Depressed net profitability
Net profitability remains materially below the prior cycle, limiting earnings resilience and reducing the return available from OMRON’s broad technology portfolio until cost pressures improve.
Read all positive and negative factors
Positive Factors
Negative Factors
Conservative balance sheet
Moderate leverage and a stable equity base provide financial flexibility and resilience during industrial downturns, allowing OMRON to continue investing in automation and healthcare capabilities.
Read all positive factors
OMRON (6645) vs. iShares MSCI Japan ETF (EWJ)
Market Cap
¥1.27T
Dividend Yield1.59%
Average Volume (3M)1.31M
Price to Earnings (P/E)39.7
Beta (1Y)1.44
Revenue Growth-2.45%
EPS Growth-1.11%
CountryJP
Employees26,050
SectorTechnology
Sector Strength88
IndustryIndustrial - Machinery
Share Statistics
EPS (TTM)164.28
Shares Outstanding206,244,870
10 Day Avg. Volume1,053,160
30 Day Avg. Volume1,306,276
Financial Highlights & Ratios
PEG Ratio0.41
Price to Book (P/B)1.04
Price to Sales (P/S)1.14
P/FCF Ratio111.59
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
¥6,000.00Price Target Upside9.51% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)243.8
Revenue Forecast (FY)¥883.21B
OMRON Business Overview & Revenue Model
Company Description
OMRON Corporation is a global enterprise operating across diverse sectors, including industrial automation, electronic and mechanical components, social infrastructure systems, and healthcare. Its Industrial Automation division offers a comprehens...
How the Company Makes Money
OMRON makes money primarily by selling products and solutions across its operating segments, with revenue recognized mainly from the sale of manufactured goods and, where applicable, accompanying services.
1) Industrial Automation / Factory Autom...
OMRON Financial Statement Overview
Summary
Income Statement
58
Neutral
Balance Sheet
74
Positive
Cash Flow
62
Positive
| Breakdown | TTM | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 787.74B | 767.35B | 801.75B | 818.76B | 876.08B | 762.93B |
| Gross Profit | 365.39B | 351.00B | 357.14B | 346.46B | 393.88B | 346.83B |
| EBITDA | 98.07B | 84.23B | 61.77B | 51.25B | 126.08B | 108.46B |
| Net Income | 32.31B | 28.49B | 16.27B | 8.11B | 73.86B | 61.40B |
Balance Sheet | ||||||
| Total Assets | 1.38T | 1.52T | 1.36T | 1.35T | 998.16B | 930.63B |
| Cash, Cash Equivalents and Short-Term Investments | 224.27B | 166.54B | 149.02B | 143.09B | 105.28B | 155.48B |
| Total Debt | 272.92B | 241.21B | 184.20B | 172.76B | 45.37B | 60.12B |
| Total Liabilities | 519.76B | 515.70B | 427.36B | 403.74B | 266.93B | 262.66B |
| Stockholders Equity | 832.08B | 835.88B | 771.88B | 786.69B | 728.47B | 665.23B |
Cash Flow | ||||||
| Free Cash Flow | 63.19B | 7.81B | 6.79B | -503.00M | 8.44B | 34.07B |
| Operating Cash Flow | 111.80B | 60.92B | 55.78B | 44.88B | 53.46B | 67.43B |
| Investing Cash Flow | -84.20B | -70.07B | -47.89B | -107.10B | -55.53B | -150.16B |
| Financing Cash Flow | 33.71B | 32.36B | -4.61B | 85.99B | -58.76B | -29.60B |
OMRON Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥19.77T | 40.90 | 13.44% | 0.77% | 16.95% | 23.91% | |
68 Neutral | ¥430.18B | 17.13 | 6.28% | 2.86% | 2.28% | -22.89% | |
68 Neutral | ¥5.75T | 24.91 | ― | 1.20% | 21.98% | 57.54% | |
67 Neutral | ¥1.27T | 39.73 | 3.56% | 1.90% | -2.45% | -1.11% | |
65 Neutral | ¥13.25T | 51.06 | 8.95% | 0.78% | 10.31% | 24.82% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥1.36T | 12.48 | 12.12% | 1.36% | 12.38% | 94.31% |
* Technology Sector Average
JP:6645
OMRON
6,527.00
2,781.82
74.28%
JP:6770
Alps Alpine Co
2,211.50
437.59
24.67%
JP:6861
Keyence
82,150.00
25,412.50
44.79%
JP:6479
MinebeaMitsumi
3,401.00
892.48
35.58%
JP:6981
Murata Manufacturing Co
7,309.00
4,917.15
205.58%
JP:6762
TDK Corporation
3,077.00
1,162.09
60.69%
OMRON Corporate Events
OMRON Lifts FY2026 Outlook on AI-Driven Automation Surge
Aug 5, 2026
OMRON reported a significant year-on-year increase in consolidated revenue and profit for the first quarter of fiscal 2026, largely driven by strong performance in its Industrial Automation Business, which captured rising AI-related demand and exp...
Omron Delivers Strong Q1 Earnings and Raises Full-Year Outlook
Aug 5, 2026
Omron reported a strong start to the fiscal year ending March 31, 2027, with first-quarter revenue rising 26.1% year on year to ¥209.9 billion and operating profit surging 226% to ¥18.9 billion. Profit attributable to owners of the paren...
OMRON Healthcare Completes Tender Offer for Matsuya R&D Shares
Jun 16, 2026
OMRON HEALTHCARE Co., Ltd., a subsidiary of OMRON Corporation, has successfully completed a tender offer for the shares and certain share options of Matsuya RD Co., Ltd., which is listed on the Tokyo Stock Exchange Growth Market. The offer, approv...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.